APA引文

Li, Z., Li, Y., Yan, S., Fu, J., Zhou, Q., Huang, X., & Shen, L. (2017). Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma. Onco Targets Ther.

Citação norma Chicago

Li, Zhanzhan, Yanyan Li, Shipeng Yan, Jun Fu, Qin Zhou, Xinqiong Huang, and Liangfang Shen. "Nimotuzumab Combined With Concurrent Chemoradiotherapy Benefits Patients With Advanced Nasopharyngeal Carcinoma." Onco Targets Ther 2017.

MLA引文

Li, Zhanzhan, et al. "Nimotuzumab Combined With Concurrent Chemoradiotherapy Benefits Patients With Advanced Nasopharyngeal Carcinoma." Onco Targets Ther 2017.